Clinical Trials Browser

OTHER × bavituximab × Genitourinary × Clear all

NCT01335204 2018-07-13

Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer

Phase 1/2 Terminated

4 enrolled 5 charts

Prostatic Neoplasms